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Background: Bluetongue virus (BTV) causes non-contagious haemorrhagic disease in ruminants and is transmitted
by Culicoides spp. biting midges. BTV encodes four non-structural proteins of which NS3/NS3a is functional in virus
release. NS3/NS3a is not essential for in vitro virus replication. However, deletion of NS3/NS3a leads to delayed virus
release from mammalian cells and largely reduces virus release from insect cells. NS3/NS3a knockout BTV in sheep
causes no viremia, but induces sterile immunity and is therefore proposed to be a Disabled Infectious Single Animal
(DISA) vaccine candidate. In the absence of viremia, uptake of this vaccine strain by blood-feeding midges would be
highly unlikely. Nevertheless, unintended replication of vaccine strains within vectors, and subsequent recombination
or re-assortment resulting in virulent phenotypes and transmission is a safety concern of modified-live vaccines.
Methods: The role of NS3/NS3a in replication and dissemination of BTV1, expressing VP2 of serotype 2 within colonized
Culicoides sonorensis midges was investigated. Virus strains were generated using reverse genetics and their growth was
examined in vitro. A laboratory colony of C. sonorensis, a known competent BTV vector, was fed or injected with BTV
with or without expressing NS3/NS3a and replication in the midge was examined using RT PCR. Crossing of the midgut
infection barrier was examined by separate testing of midge heads and bodies.
Results: Although the parental NS3/NS3a expressing strain was not able to replicate and disseminate within C. sonorensis
after oral feeding, this virus was able to replicate efficiently when the midgut infection barrier was bypassed by
intrathoracic injection, whereas the NS3/NS3a knockout mutant was unable to replicate. This demonstrates that
NS3/NS3a is required for viral replication within Culicoides.
Conclusion: The lack of viremia and the inability to replicate within the vector, clearly demonstrate the inability of
NS3/NS3a knockout DISA vaccine strains to be transmitted by midges.
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Arthropod-borne viruses (arboviruses) have a significant
social and economic impact on both human and animal
health. A majority of all emerging and re-emerging
infectious diseases are vector-borne or zoonotic [1, 2].
Combating arboviral diseases requires an interdisciplinary
approach, possibly including vector control, surveillance
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tongue virus (BTV, family Reoviridae, genus Orbivirus) [4]
and Schmallenberg virus (family Bunyaviridae) [5] are
examples of emerging arboviruses in countries with a
moderate climate, which are transmitted by Culicoides
(Diptera: Ceratopogonidae) biting midges [6–8]. BTV in-
fection results in a haemorrhagic disease of domestic and
wild ruminants called Bluetongue (BT). In cattle, BT is
typically subclinical, but infection in sheep can result in
severe disease with high mortality [9]. Due to the wide
host range, prolonged viremia with often less-severe
disease symptoms, and virus spread by midges, outbreakle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Fig. 1 Culicoides midge with the several different body parts; head,
thorax and abdomen, indicated. Salivary glands (1) are located in
the head/thorax. The digestive tract contains the forgut (2) and
midgut (3), where food is digested and the hindgut (4), where
faeces forms. Important dissemination barriers are located at the
level of the midgut and salivary glands. Figure partly adapted from
Alan R. Walker (Veterinary Research Laboratory, Kenya)
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cination [3].
BTV is a non-enveloped virus with a complex triple-
layered capsid containing the ten-segmented double
stranded (ds) RNA genome and the replication complex.
In addition to seven structural proteins (VP1-7), BTV en-
codes four non-structural (NS) proteins [10–12]. The virus
release mechanism differs for mammalian and insect cells,
with insect cells showing non-lytic release, whereas cell
lysis is the prominent release mechanism in mammalian
cells [13]. Virus particles can leave the cell by budding, ac-
quiring a temporary envelope, but also via disruption of
the cell membrane [13, 14].
NS3 and N-terminal truncated NS3a are viroporin-like
membrane proteins [15, 16], functional in virus release
[17, 18]. NS3/NS3a is expressed in larger amounts in in-
sect cells and is hypothesized to be mainly important for
the non-lytic release from these cells [19–23]. NS3/NS3a
comprises a long N-terminal domain, two transmembrane
domains with a short extracellular domain in between,
and a shorter C-terminal cytoplasmic domain [24]. Inter-
action with the p11 cellular calpactin complex subunit
and recruitment of the ESCRT-I TsgI protein [25–27],
highlights involvement in membrane trafficking/modifica-
tion and virus release. Recently, we showed that expres-
sion of NS3/NS3a is not essential for BTV replication
in vitro. However, release of NS3/NS3a knockout mutants
from mammalian cells is significantly delayed and release
from insect cells is strongly reduced [28].
By inducing an out of frame deletion in BTV Seg-10, en-
coding NS3/NS3a, using reverse genetics, knockout BTV
viruses were generated. A BTV vaccine strain with such a
Seg-10 deletion has been described to be a very promising
vaccine candidate, named the disabled infectious single
animal (DISA) BT vaccine. Sheep have been vaccinated
with this virus, and no clinical signs after vaccination were
induced. Vaccine virus replicated only locally and sterile
protection to virulent BTV infection was induced [29–31].
Since vaccination did not result in detectable viremia of
BT DISA vaccine virus, oral uptake of the vaccine by in-
sect feeding is highly unlikely.
Oral infection of midges with BTV and subsequent
virus transmission to the ruminant host is complex and
differs even between individuals of one Culicoides spe-
cies. This leads to variable proportions of individuals
within a midge population being susceptible to oral virus
infection or capable of virus transmission. Vector arthro-
pods present several ‘barriers’ which could prevent infec-
tion, dissemination, or transmission of the arbovirus to
the susceptible host. For the Culicoides vector, a midgut
infection barrier (MIB), a midgut escape barrier (MEB)
and a dissemination barrier have been identified (Fig. 1)
[32–34]. Since NS3/NS3a has a prominent role in virus re-
lease in insect cells in vitro, we now considered whetherpropagation of DISA vaccine virus, not expressing NS3/
NS3a, would be significantly diminished or blocked in
BTV-competent Culicoides biting midges in vivo. This
blockade would improve the safety of replicating BT DISA
vaccine by minimizing the risk on uncontrolled vaccine
spread. Therefore, we here investigated the propagation of
a DISA vaccine based on BTV1, expressing VP2 of sero-
type 2, after oral infection and intrathoracic injection of in
Culicoides sonorensis (formerly Culicoides variipennis
sonorensis) [35], a species known to vector several BTV
serotypes including U.S. BTV2 [36].
Methods
Cells and viruses
BSR cells (a clone of BHK-21 cells [37]) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen),
with 5 % fetal bovine serum (FBS), 100 IU ml−1 Penicillin,
100 μg ml−1 Streptomycin and 2.5 μg ml−1 Amphotericin
B, at 37 °C with 5 % CO2. KC cells [19] derived from em-
bryos of colonized Culicoides sonorensis Wirth & Jones
[38] were grown in modified Schneider’s Drosophila
medium with 15 % FBS, 100 IU ml−1 Penicillin and
100 μg ml−1 Streptomycin at 27 °C.
BTV1 generated by reverse genetics (Genbank accession
numbers FJ969719-FJ969727) with Seg-10 originating from
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ate BTV1 derivatives using reverse genetics as previously
described [39, 40]. cDNA of Seg-2 of BTV2 (JN255863)
was used for single Seg-2 exchange (BTV1[VP2]2). cDNA
of Seg-10 originating from BTV8 with the out-of-frame de-
letion ΔC (bp 102–263) was used to generate NS3/NS3a
knockout BTV with VP2 of serotype 2 (DISA 2) [41]. The
positive control field strain of BTV11 was isolated from
the spleen of a white-tailed deer from Texas in 2011, pas-
saged once in embryonated chicken eggs, and four times
in BHK-21 cells before use in midge feeding/injecting.
Virus stocks were produced by infection of BSR cells
at low multiplicity of infection (MOI), and were har-
vested by freeze-thawing when > 50 % of cells immuno-
stained as BTV-positive with α VP7 monoclonal
antibody (MAb) ATCC-CRL-1875 in a duplicate well, or
when > 50 % of cells showed cytopathogenic effect
(CPE). Virus in clarified supernatant was concentrated
using 3 K centrifugal filters (Amicon Ultracel-3 K) and
centrifugation for 30 min at 4000 rpm. Seg-2 was con-
firmed by serotype specific PCR testing with primers tar-
geting Seg-2 (BTV2 Seg-2 F 5′-TCAAAGATGAGGG
GATACGG-3′ and BTV2 Seg-2 R 5′-AAGCGGCTGTT
GATCCATAC-3′), and Seg-10 using PCR with Seg-10
primers (F-full-S10* 5′-GTTAAAAAGTGTCGCTGC
C-3′ and R-full-S10 5′-GTAAGTGTGTAGTGTCGC
GCAC-3′) followed by sequencing as described previ-
ously [31].
Virus titers were determined by endpoint dilution on
BSR cells and expressed as 50 % tissue culture infectious
dose per ml (TCID50 ml
−1). The titer of the BTV1[VP2]2
virus stock was 106.4 TCID50 ml
−1, DISA 2 had a titer of
105.8 TCID50 ml
−1(intended dose for insect experiments
was 106 TCID50/ml). Wild type BTV11, used as a posi-
tive control, had a titer of 108.2 TCID50ml
−1.
CPE and protein expression of BTV1[VP2]2 and DISA
2 virus were determined using immunostaining of infected
BSR monolayers with α VP7 MAb ATCC-CRL-1875 or
with α NS3 MAb 31E9 (Ingenasa, Madrid, Spain) using
standard procedures [42].In vitro virus release assay
Monolayers of KC cells (5 × 106) or BSR cells (5 × 105) in
2 cm2 wells were infected with an MOI of 0.01. Virus was
adsorbed for 1.5 h at 27 °C or 37 °C for KC and BSR cells
respectively. Unattached virus was removed by washing
with PBS, and fresh medium was added. This time point
was set as 0 h post-infection (hpi). Incubation was contin-
ued and cells and culture media were harvested at indi-
cated time points. Cells were lysed to be able to study the
intracellular BTV fraction, by freeze thawing at −80 °C.
Virus titers were determined and growth experiments
were independently repeated.Insect feeding and sampling
Colonized 3–4 day old female C. sonorensis midges from
the Arthropod-Borne Animal Diseases Research Unit,
Manhattan, KS, USA [43] were offered a blood meal,
consisting of 1:1 (v/v) defibrinated sheep blood and virus
stock at highest titer available, in an artificial feeder
using a parafilm membrane [44]. Midges were allowed
to feed for 2 h, removed from the blood source, anesthe-
tized for 10–15 s with CO2, removed from the feeding
cage, and sorted as to blood-feeding status on a CO2 fly
pad (Diamed Lab Supplies, Inc., Mississauga, Ontario,
CA). Engorged females were put in cardboard cages with
cotton-plugged vials containing 10 % sucrose and held at
26 °C. At 0, 7, 10 (BTV11 control only) and 14 days post
feeding (dpf), 50 midges were anesthetized with CO2and
heads were separated from bodies using ultra-fine tweezers
(EMS Hatfield, PA, USA) and a dissecting microscope
(SMZ 1500; Nikon Instruments, Melville, NY, USA). Heads
and bodies were separately placed in 100 μl RNAlater
(Qiagen, Germantown, MD, USA), and stored at 4 °C.
Insect inoculation
Colonized 3–4 day old female C. sonorensis midges were
injected intrathoracically with 46 nl of virus stock using
the Nanoject II microinjector (Drummond Scientific,
Broomall, PA, USA) under a dissecting microscope (Nikon
Instruments). This volume was based on hemocoel injec-
tion capacity of the midges, highest rate of consistency,
complete fluid retention, and maximum post inoculation
survival. Total virus injected per midge, based on highest
starting virus stock titers possible, was 101.5 TCID50 of
DISA 2 and 102.1 TCID50 of BTV1[VP2]2 virus. Inoculated
midges were placed in cardboard cages with cotton-
plugged vials containing 10 % sucrose and held at 26 °C.
At 0, 7, and 10 days post inoculation, 25 midges were anes-
thetized, decapitated and stored in RNA later (Qiagen) at
4 °C as described above. Time 0 samples were taken from
1 to 4 h post-injection. This variation was due to the time-
intensive nature of microinjecting large numbers of midges
needed to ensure adequate numbers of surviving midges
for each time point.
RNA isolation and PCR
PBS (400 μl) and one 5 mm stainless steel ball (Qiagen)
were added to midge bodies and heads in RNA later in
micronic tubes. Tubes were shaken for 3 min at 50 Hz in
a tissue lyser (85600, Qiagen). After centrifugation, 200 μl
of supernatant was used for RNA isolation using the
MagNApure 96 DNA and viral NA Small Volume kit
(Roche) by the MagNApure isolation robot (Roche)
according to the manufacturer’s protocol [45]. The real-
time RT-PCR test for Seg-1 was performed using primer
F-pan-S1 (5′-TTAAAATGCAATGGTCGCAATC-3′), pri-
mer R-pan-S1 (5′-TCCGGATCAAGTTCACTCC-3′) and
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3’) [46] according to the all-in-one method, including the
pre-denaturation step, as described for the pan BTV Seg-
10 PCR test [45]. Crossing point (Cp) values of each PCR
were calculated, and negative results were arbitrarily set as
45 to allow these to be included in the analysis. Due to the
maximum of 45 cycles, the highest Cp value that could still
be calculated was 40. Statistical differences in Cp values
were calculated using a one way ANOVA and subsequent
Tukey’s multiple comparison test, with p < 0.001 indicating
significant differences between days or groups.
Results
NS3/NS3a is required for release from Culicoides cells
in vitro
Similar to previous results with NS3/NS3a knockout mu-
tant viruses [28], DISA 2 did not induce CPE in BSR cells.
Immunostaining of VP7 indicated BTV replication, but
NS3/NS3a expression could not be detected. In contrast,
BTV1[VP2]2 parental virus induced CPE and was immu-
nostained with both VP7 and NS3 MAbs (Fig. 2a). Sequen-
cing of Seg-10 of DISA 2 confirmed the ΔC deletion, and
thus the absence of NS3/NS3a expression by DISA 2. No
additional insertions or deletions in Seg-10 of DISA 2 were
identified (not shown). In agreement to previous resultsFig. 2 BSR monolayers were infected with BTV1[VP2]2 or DISA 2 and immu
infections (red colour), whereas NS3/NS3a is only detectable in the BTV1[VP
cells (b) and KC cells (c) was also examined. Both virus in the cell fraction (
performed in duplicate and error bars represent SEM[28], release of DISA 2 from BSR cells was slightly delayed
compared to the parent virus, with clear increase examined
at 48 h post infection, compared to 16 h post infection for
BTV1[VP2]2 (Fig. 2b). The virus titer in the cells was
higher for BTV1[VP2]2 (107.2 TCID50 ml
−1) compared to
DISA 2 (104.9TCID50 ml
−1) at the end of the experiment at
72 h post infection. Release of virus was also reduced for
DISA 2 (103.1 TCID50 ml
−1) compared to the parental virus
(106.5TCID50 ml
−1). Growth in KC cells was highly attenu-
ated, with ten-fold lower virus titer in both the cell fraction
and the released fraction for DISA 2 at the end of the ex-
periment. DISA 2 virus release was diminished, with 102.1
TCID50 ml
−1 at 0 dpi and still only 102.6 TCID50 ml
−1 at
120 dpi, the end of the experiment (Fig. 2c).
C. sonorensis midges can be infected orally with BTV11,
but not with BTV1[VP2]2
BTV11-fed midges were harvested at day 0, 7, 10 and 14
dpf. For each day of sampling, heads and bodies of 25
midges were harvested and were tested individually.
Viral RNA was isolated for PCR testing and semi-
quantitated by Cp values (Fig. 3). Directly after feeding
(day 0), all bodies were PCR positive (mean Cp: 25.3, range
27–23.9), whereas heads were negative (13 out of 25) or
had very high Cp values (mean Cp:39.5). As blood mealsnostained with α NS3 or VP7 MAbs. Clearly, VP7 is expressed in both
2]2 infected cells (a). Release of BTV1[VP2]2 and DISA 2 virus on BSR
black) and released virus (grey) was measured. Experiments were
Fig. 3 Colonized C. sonorensis were fed with blood containing BTV11 or BTV1[VP2]2. Viral RNA was detected and semi quantitated by PCR expressed
in Cp values for individual heads and bodies at day 0 (light grey dots), day 7 (dark grey squares), day 10 (open diamonds) and day 14 (light grey
triangles) post feeding. The mean Cp values (black line) and significant (p < 0.001) different Cp values from the respective day 0 value (*) are indicated
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(mean Cp: 30.5, range 45–22.3), was slightly higher, but de-
creased significantly until day 10 (mean Cp: 26.7, range 40–
22.5) (p < 0.001), indicating virus replication in the midge.
From day 10 to 14 (Cp: 26.1, range 45–22.7), no significant
difference was found, suggesting no further increase of the
virus titer in midge bodies. To study the ability of BTV11
to cross the midgut barrier and to replicate in the
midge, viral RNA in the heads was determined. Cp values
were significantly lower at day 7 (mean Cp: 34.5,range
45–26.1), day 10(mean Cp: 31.4,range 45–27);and day
14 (mean Cp:29.9,range 40–26.7) compared to day 0
(p < 0.001) and were declining in time. This clearly
demonstrated midgut escape and virus replication in col-
onized C. sonorensis by BTV11.
Similarly, 50 BTV1[VP2]2 fed midges were harvested at
day 0, 7 and 14, and tested by PCR. At day 0, directly after
feeding, bodies showed Cp values (mean Cp: 26.1, range
27–23.5) not significantly different from that of bodies of
BTV11 fed midges. At day 7, 40 out of 50 bodies were
PCR negative, and at day 14 post feeding only 6 out of 50
bodies had a Cp value of 40. All heads were PCR negative
at day 0, 7 and 10, except for one head at day 0 and 7
(Cp:40). These results indicated that BTV1[VP2]2 was
unable to infect the midgut epithelium and was unable to
escape the midgut barrier in C. sonorensis. Feeding with
DISA 2 virus was also performed, but harvested heads and
bodies were not further processed because of the negative
results of the BTV1[VP2]2 parental strain.
NS3/NS3a is required for propagation of artificially
disseminated BTV in C. sonorensis
Intrathoracic injection of virus into the hemocoel of
midges can lead to replication of virus unable to naturallyescape the midgut following oral uptake [32, 47]. There-
fore, to study virus propagation in the absence of a midgut
barrier, midges were injected with the parent strain
BTV1[VP2]2 and its NS3/NS3a knockout derivative DISA
2. Groups of 25 injected midges were harvested at day 0,
7, and 10 post injection. Viral RNA in heads and bodies
was individually tested and semi-quantitated by PCR
(Fig. 4).
On day 0, RNA was detected in all bodies for
BTV1[VP2]2 (mean Cp: 31.3, range 40–30) and DISA 2
(mean Cp: 32.7, range 36.1-31). There was no significant
difference between both groups. Injected virus was also
detected in the heads of 23 out of 25 midges on day 0
due to dissemination throughout the hemocoel. At both
day 7 and 10 post injection of BTV1[VP2]2, mean Cp
values in the bodies were 23.7 and 23.2 (range: 26.5-21.9
and 24.4-20.3 respectively), indicating significantly
higher RNA levels than that of input virus. In addition,
Cp values of tested heads on these days were also signifi-
cantly lower (p < 0.001) (28.5 and 28.2 with a range of
31.5-26.4 and 29.9-26.5, respectively) compared to day 0
(mean Cp: 36.1). These results clearly indicate virus
propagation of BTV1[VP2]2 throughout injected C.
sonorensis midges.
In contrast, DISA 2 injected midges did not show sig-
nificantly lower Cp values in the bodies in time, with
mean Cp values of 32.7, 33.5 and 33.9 for day 0, 7, and
10, respectively. In the heads of DISA 2 injected midges,
Cp values were significantly lower (p < 0.001) at day 7
(mean Cp: 37.5, range 45–31.8) compared to day 0
(mean Cp: 40.5 range 45–35.6). However, at day 10, the
mean Cp value was not significantly different from day 0
(mean Cp: 39.3, range 45–32.1). Remarkably, even at the
day 0 time point (1–4 hpi), DISA 2 injected midges had
Fig. 4 Colonized C. sonorensis were injected with BTV1[VP2]2 or DISA 2.Viral RNA was detected and semi quantitated by PCR expressed in Cp values
for individual heads and bodies indicated at day 0 (light grey dots), day 7 (dark grey squares) and day 10 (open diamonds) post injection. The mean
Cp values (black line) and significant (p < 0.001) different Cp values from the respective day 0 value are indicated (*)
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heads compared to BTV1[VP2]2 (mean Cp: 36.1, range:
45–32.7). Unlike the parent BTV1[VP2]2 virus strain,
DISA 2 was unable to propagate after injection of colo-
nized C. sonorensis. Because these viruses only differ in
NS3/NS3a expression, we conclude that NS3/NS3a
proteins play a crucial role in virus propagation in the
insect vector.
Discussion
Recently, we have shown that NS3/NS3a is not essential
for virus replication in vitro [28]. A novel BT vaccine can-
didate based on live-attenuated BTV lacking NS3/NS3a
expression has been developed and is named the disabled
infectious, single animal (DISA) vaccine [28–31, 41]. NS3/
NS3a expression is more prominent in insect cells [19–23],
and important for virus release from cultured midge cells
in vitro [28]. Here, the role of NS3/NS3a in virus propaga-
tion was studied in vivo in midges.
We compared a reverse genetics derived parent strain
BTV1[VP2]2 (BTV1 expressing VP2 of serotype 2) with
the same virus containing a deletion in Seg-10, which
abrogates NS3/NS3a expression (DISA 2). Virus growth
of DISA 2 in mammalian cells (BSR) is inhibited by the
NS3/NS3a knockout mutation, and is delayed (Fig. 2b).
Both release and growth of DISA 2 in Culicoides cells is
strongly attenuated by the NS3/NS3a knockout muta-
tion (Fig. 2c). BTV1[VP2]2 and DISA 2 grow to lower
titers in BSR cells, compared to similar viruses with
other serotypes, as already observed in earlier studies
[30]. So apparently, serotyping with VP2 from serotype 2
influences in vitro growth in a negative manner, likely by
disturbing infection.Initially, we compared oral infection of C. sonorensis
with BTV1[VP2]2 and an American BTV11 isolate. This
BTV11 isolate was included to confirm ‘normal’ feeding
behaviour of this specific midge colony and was fed with
a very high dose of 108.2 TCID50 ml
−1, since this dose
led to virus replication in numerous previous experi-
ments (not shown). Unfortunately, the BTV1[VP2]2
strain was not able to escape the midgut barrier as
evidenced by the lack of viral RNA in the heads. The
results of day 0 post feeding suggests a similar starting
dose in the midguts of both groups by PCR testing.
However, the blood meal for BTV1[VP2]2 contained
100 times less infectious virus than that of BTV11 as
determined by titration. This might be explained by the
presence of non-infectious particles in the BTV1[VP2]2
virus stock, although this needs further investigation. The
lower dose could explain the negative results for
BTV1[VP2]2, but a similar dose of about 106 TCID50 ml
−1
of BTV1, as used in our study for BTV1[VP2]2,has been
used already successfully in several vector competence
studies using C. sonorensis [32, 33, 48, 49]. Therefore, it is
highly unlikely that the used dose is too low to be able to
infect the midges and it is not expected that a higher dose
would have led to BTV1[VP2]2 replication. In further sup-
port of this conclusion, intrathoracic injection of only
46 nl of the same virus stock resulted to similar Cp values
at day 0, proficient for virus replication, while it is
estimated that fully engorged C. sonorensis midges ingest
approximately 50–100 nl of blood (personal communi-
cation B. Drolet, U.S. Department of Agriculture). This
volume correlates to 50–100 TCID50 of virus per blood
meal when feeding with viremic blood containing 106
TCID50 of BTV ml
−1.
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transmission-competent vectors for various serotypes of
BTV [32, 50–53]. Vector competence for a specific arbo-
virus is affected by multiple factors during the virus-vector
interaction, including viral genetics, vector genetics, gut
microbiota, physiological barriers, salivary components,
environmental temperature, and vector innate immunity
[32, 33, 54–57]. Physiological barriers include the MIB,
MEB, salivary gland infection barrier and salivary gland es-
cape barrier. For bite transmission of virus after ingestion
of BTV1[VP2]2 or DISA2 strain, viruses must exit the
midgut (with or without infection), enter the hemocoel,
disseminate, and then infect and escape the salivary glands.
Based on the PCR results of bodies and heads of orally in-
fected midges, BTV1[VP2]2could not overcome the MIB
or MEB, since no virus replication in the bodies and no
dissemination to heads was observed. This strongly
indicates that, C. sonorensis is not competent for this re-
combinant virus. No propagation of parental NS3/NS3a
expressing strains in the midge vector could make the
DISA vaccine even safer regarding vaccine virus spread in
the field. Intrathoracic inoculation was performed to
circumvent the midgut barriers and to study the ability of
disseminated BTV1[VP2]2 and DISA 2 to propagate
within Culicoides.
Replication of BTV is likely after intrathoracic injec-
tion, even for viruses that do not replicate in the midge
after oral uptake [32]. Indeed, in contrast to oral uptake,
BTV1[VP2]2 propagated in injected midges. As ex-
pected, DISA 2 virus was detected in the heads directly
after injection due to dissemination in the hemocoel. The
amount of DISA 2 virus RNA was significantly less in
heads (p < 0.001) (higher Cp), compared to BTV1[VP2]2
at day 0. This might be due to possible variations in exact
sampling times post inoculation for the day 0 time point
(1–4 hpi) or differences in amount of virus delivered in
the 46 nl injection (101.5 vs. 102.1). Less time between in-
jection and decapitation could lead to incomplete dissem-
ination of virus to the head via the hemolymph.
Significantly higher DISA 2 RNA levels (lower Cp value)
were measured in the heads at day 7 compared to day 0,
which is likely due to full dissemination of injected virus
at this time point. Indeed, the Cp value at day 10 was
higher again compared to day 7, suggesting degradation of
viral RNA. A few individual bodies and heads of DISA 2
fed midges showed a Cp value lower than the average at
day 7 and 14. This might indicate a low level of replication
in these midges. However, compared to BTV1[VP2]2 fed
midges, Cp values are still high, and spread via the salivary
glands to the ruminant host is highly unlikely.
Conclusions
In conclusion, NS3/NS3a knockout strongly reduces virus
release and propagation in the midge after injection, oncethe midgut barrier has been passed. This is likely due to the
strongly reduced virus release, also seen Culicoides cells. It
is also possible that the delayed release of DISA 2 from the
cell results in faster virus clearance by intracellular innate
immunity such as RNAi [58, 59], Toll-Imd, Jak-STAT, NfkB,
and autophagy [60].
The virus backbone used in DISA vaccines is based on
non-virulent BTV and is safe with respect to fever and
clinical signs [61]. Currently, the DISA principle is based
on the absence of viremia in the vertebrate host, thereby
preventing uptake by insect vectors [29]. Here, the safety
of the DISA principle is supported by the absence of
DISA 2 propagation in C. sonorensis.
Live-modified vaccines for orbiviruses potentially
imply several risks, such as reversion to virulence, re-
assortment events and uncontrolled spread of vaccine
virus. An elegant method to combat these major dis-
advantages is to target functions that are specific and
essential for virus propagation in the insect vector,
and for virus transmission between host and vector.
Most likely, similar NS3/NS3a deletion mutants for
other orbiviruses will have similar characteristics [62],
whereas targeting functions essential for vector trans-
mission in other arboviral pathogens will also result
in safe vaccine candidates.Competing interests
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